[Corrections] Correction to Lancet Oncol 2023; 24: 1042–52

Umemura Y, Orringer D, Junck L, et al. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial. Lancet Oncol 2023; 24: 1042–52—In this Article the funding statements in the summary and the acknowledgments have been corrected. These corrections have been made to the online version as of Oct 2, 2023.